Clinical Trial: A Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: An International, Cross Sectional, Non-interventional, Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndr

Brief Summary: The purpose of the protocol is to to assess subject's overall satisfaction regarding control of diarrhea. The study aims to supplement results obtained through clinical trials with data obtained from a population of patients receiving treatment with Somatuline Autogel in routine practice.

Detailed Summary:
Sponsor: Ipsen

Current Primary Outcome: Subject's overall satisfaction regarding control of diarrhea [ Time Frame: Day of survey ]

Use of questionnaires to assess patient satisfaction (Likert scale).


Original Primary Outcome: Same as current

Current Secondary Outcome: Impact on daily activities of the clinical manifestations of diarrhea [ Time Frame: Day of survey ]

Use of questionnaires to assess symptom severity and impact on patient's daily activities (CGI-S).


Original Secondary Outcome: Same as current

Information By: Ipsen

Dates:
Date Received: October 20, 2010
Date Started: October 2010
Date Completion:
Last Updated: January 30, 2017
Last Verified: January 2017